Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer

被引:0
|
作者
Jin Sung Koh
Moon Kyung Joo
Jong-Jae Park
Hyo Soon Yoo
Byung Il Choi
Beom Jae Lee
Hoon Jai Chun
Sang Woo Lee
机构
[1] Korea University College of Medicine Guro Hospital,Division of Gastroenterology, Department of Internal Medicine
[2] Korea University College of Medicine Anam Hospital,Division of Gastroenterology, Department of Internal Medicine
[3] Korea University College of Medicine Ansan Hospital,Division of Gastroenterology, Department of Internal Medicine
来源
关键词
Pantoprazole; Gastric cancer; SH2-containing protein tyrosine phosphatase 1; Signal transducer and activator of transcription 3;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Elimination of ALDH plus breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling
    Xiong, Ailian
    Yu, Weiping
    Liu, Yaobin
    Sanders, Bob G.
    Kline, Kimberly
    MOLECULAR CARCINOGENESIS, 2016, 55 (05) : 420 - 430
  • [32] Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells
    Chun-Yu Liu
    Ling-Ming Tseng
    Jung-Chen Su
    Kung-Chi Chang
    Pei-Yi Chu
    Wei-Tien Tai
    Chung-Wai Shiau
    Kuen-Feng Chen
    Breast Cancer Research, 19
  • [33] Leonurine ameliorates the STAT3 pathway through the upregulation of SHP-1 to retard the growth of hepatocellular carcinoma cells
    Jung, Young Yun
    Kim, Chulwon
    Shanmugam, Muthu K.
    Deivasigamani, Amudha
    Chinnathambi, Arunachalam
    Alharbi, Sulaiman Ali
    Rangappa, Kanchugarakoppal S.
    Hui, Kam Man
    Sethi, Gautam
    Mohan, Chakrabhavi Dhananjaya
    Ahn, Kwang Seok
    CELLULAR SIGNALLING, 2024, 114
  • [34] Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma
    Sarita Saraswati
    Abdulqader Alhaider
    Abdelgalil Mohamed Abdelgadir
    Pooja Tanwer
    Hesham M. Korashy
    Cell Communication and Signaling, 17
  • [35] Targeting STAT3 in gastric cancer
    Giraud, Andrew S.
    Menheniott, Trevelyan R.
    Judd, Louise M.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (09) : 889 - 901
  • [36] A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3
    Huang, C. Y.
    Tai, W. T.
    Hsieh, C. Y.
    Lai, Y. J.
    Hsu, W. M.
    Chen, L. J.
    Shiau, C. W.
    Chen, K. F.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S174 - S174
  • [37] A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3
    Huang, Chao-Yuan
    Tai, Wei-Tien
    Hsieh, Chi-Ying
    Hsu, Wan-Mai
    Lai, Ying-Jiun
    Chen, Li-Ju
    Shiau, Chung-Wai
    Chen, Kuen-Feng
    CANCER LETTERS, 2014, 349 (02) : 136 - 143
  • [38] Euphorbiasteroid Induces Apoptosis as Well as Autophagy through Modulating SHP-1/STAT3 Pathway in Hepatocellular Carcinoma Cells
    Kim, Na Young
    Sethi, Gautam
    Um, Jae-Young
    Ahn, Kwang Seok
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [39] Ellagic acid induces esophageal squamous cell carcinoma cell apoptosis by modulating SHP-1/STAT3 signaling
    Xu, Ying-Ying
    Wang, Wan-Wei
    Huang, Jing
    Zhu, Wei-Guo
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2020, 36 (09): : 699 - 704
  • [40] Fangchinoline diminishes STAT3 activation by stimulating oxidative stress and targeting SHP-1 protein in multiple myeloma model
    Jung, Young Yun
    Ha, In Jin
    Um, Jae-Young
    Sethi, Gautam
    Ahn, Kwang Seok
    JOURNAL OF ADVANCED RESEARCH, 2022, 35 : 245 - 257